Browse Category

ASX:4DX News 19 December 2025 - 19 January 2026

4DMedical (4DX) share price slips after $150m raise — what investors watch next

4DMedical (4DX) share price slips after $150m raise — what investors watch next

Sydney, January 19, 2026, 17:29 AEDT — The market has closed. 4DMedical Ltd shares dropped 4.3% on Monday, closing at A$4.86 after fluctuating between A$4.76 and A$5.42. The lung-imaging stock pulled back following a strong rally. An investor presentation was released in the morning, but the stock slipped by late afternoon. (Intelligent Investor) Timing is key. 4DMedical is just days from closing a A$150 million institutional placement priced at A$3.80 per share, with the new shares set to start trading on January 22. The company said this capital raise, along with a related sale of existing shares, will boost its
19 January 2026
4DMedical shares jump on UC San Diego Health CT:VQ rollout as market eyes next catalyst

4DMedical shares jump on UC San Diego Health CT:VQ rollout as market eyes next catalyst

Sydney, Jan 7, 2026, 17:44 AEDT — Market closed Shares of 4DMedical Ltd (ASX:4DX) climbed 11.9% to close at A$4.69 on Wednesday after the firm said UC San Diego Health had adopted its CT:VQ lung imaging software for clinical use. About 12.8 million shares traded, MarketScreener data showed. MarketScreener+1 The contract adds a fourth U.S. academic medical centre — a university-linked teaching hospital — to deploy CT:VQ since the product won U.S. Food and Drug Administration clearance in August, sharpening investor focus on commercial traction. UCSD will use introductory pricing through March 31 before moving to full commercial terms, the
4DMedical (ASX:4DX) Share Price Surge: What Happened on 18 December 2025, Why CT:VQ Is Driving the Rally, and What Comes Next

4DMedical (ASX:4DX) Share Price Surge: What Happened on 18 December 2025, Why CT:VQ Is Driving the Rally, and What Comes Next

4DMedical (ASX:4DX) has become one of the most talked-about Australian small-cap healthcare names of late 2025—despite a bruising year for the broader sector. On 18 December 2025, fresh market coverage put the spotlight back on the stock’s extraordinary run and the commercial milestones behind it, as investors weighed a familiar question for fast-rising growth stories: is this the start of something bigger, or has the market moved too far, too fast? Livewire Markets The key news on 18 December 2025: a “small-cap sensation” goes mainstream The day’s most widely shared piece of coverage came from Livewire Markets, which framed 4DMedical

Stock Market Today

CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

7 February 2026
CapitaLand Investment shares rose 1.3% to S$3.12 on Friday, bucking a 0.8% drop in Singapore’s benchmark index. CapitaLand Integrated Commercial Trust reported a 16.4% jump in second-half distributable income, while CapitaLand Ascendas REIT posted a 1.4% full-year rise. CapitaLand China Trust saw full-year DPU fall to 4.82 cents amid weaker yuan and occupancy. CLI reports FY2025 results on Feb. 11.
Keppel stock holds near 12-year high after profit jump, special dividend; buyback adds support

Keppel stock holds near 12-year high after profit jump, special dividend; buyback adds support

7 February 2026
Keppel shares closed at S$11.64 on Friday, up 0.17%, after surging 6.1% the previous day on stronger FY2025 profit and a larger dividend plan. The company bought back 151,400 shares for about S$1.74 million. Keppel reported a 29% rise in full-year profit to S$1.02 billion and proposed a total distribution of 47 cents per share, including a special dividend partly paid in Keppel REIT units.
Go toTop